Skip to main content

DNA methyltransferase 3 alpha

The DNMT3A gene provides instructions for making an enzyme called DNA methyltransferase 3 alpha. This enzyme is involved in DNA methylation, which is the addition of methyl groups, consisting of one carbon atom and three hydrogen atoms, to DNA molecules. In particular, the enzyme helps add methyl groups to DNA building blocks (nucleotides) called cytosines.

Video picks for Genes
Video library

Normal function

The DNMT3A gene provides instructions for making an enzyme called DNA methyltransferase 3 alpha. This enzyme is involved in DNA methylation, which is the addition of methyl groups, consisting of one carbon atom and three hydrogen atoms, to DNA molecules. In particular, the enzyme helps add methyl groups to DNA building blocks (nucleotides) called cytosines.

DNA methylation is important in many cellular functions. These include determining whether the instructions in a particular segment of DNA are carried out or suppressed (gene silencing), regulating reactions involving proteins and fats, and controlling the processing of chemicals that relay signals in the nervous system (neurotransmitters). DNA methyltransferase 3 alpha is particularly important for establishing DNA methylation patterns during development before birth. The enzyme also functions in early cells that can give rise to more mature cell types. In early blood cells, called hematopoietic stem cells, the methylation patterns established by DNA methyltransferase 3 alpha promote maturation (differentiation) into different blood cell types.

Conditions referring to this gene or chromosome

Other names

DNA (cytosine-5)-methyltransferase 3A

DNA (cytosine-5-)-methyltransferase 3 alpha

DNA cytosine methyltransferase 3A2

DNA MTase HsaIIIA

DNM3A_HUMAN

DNMT3A2

M.HsaIIIA

Patient picks for Genes

Related patient information and medicines

Parkinson's disease

Patient information leaflet

Parkinson's disease

PatientPicksPlaceholder Parkinson's disease stages There are 5 stages of Parkinson's disease, according to the severity of the symptoms: Stage 1 : the earliest stage. Features include mild ... Sometimes these medicines are used in combination with levodopa in the later stages of PD. Other medicines used for PD Catechol-O-methyltransferase (COMT).

Genetic testing

Patient information leaflet

Genetic testing

Genetic testing is a type of medical test that identifies changes in chromosomes, genes or proteins. Genetic tests examine a person's DNA in a variety of ways to assess a person's genetic health. They are all designed to identify a particular gene that may cause a genetic disorder. We all have 46 chromosomes in our cells. Chromosomes are made from.

Liver function tests

Patient information leaflet

Liver function tests

Each of these is discussed below. The liver performs hundreds of different functions, so there are many other possible tests that look at its health. These would normally be done if an abnormality is found with the basic liver function tests described here, or if a specific problem is suspected. They might include: Virus tests - for example, for.

Muscular dystrophy

Patient information leaflet

Muscular dystrophy

What is muscular dystrophy. Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time). There are many different types of MD. The different types vary... What causes muscular dystrophy. The cause is an abnormal or 'faulty' gene. Genes are made from a biological.

Liver failure

Patient information leaflet

Liver failure

Releasing bile, which passes into the gut (bowel) to help break d... How common is liver failure. Acute liver failure is very uncommon: In England , there were 688 liver transplants, 28 in Scotland, 69 in Wales and 24 in Northern Ireland performed in the year April 2021 to April 2022. The number of transplants increased by 11% from the previous.

Alpha-1 antitrypsin deficiency

Patient information leaflet

Alpha-1 antitrypsin deficiency

Alpha-1 antitrypsin deficiency is an inherited genetic condition. A genetic condition is one that can be passed on from parents through genes. In alpha-1 antitrypsin defic... A genetic condition is one that can be passed on from parents through genes. It was first described in 1963 by Dr Sten Eriksson, a Danish doctor. In the centre (nucleus) of.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 10 Apr 2023 | Latest version
  • 1 Sept 2017 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.